GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Icecure Medical Ltd (NAS:ICCM) » Definitions » Earnings per Share (Diluted)

Icecure Medical (Icecure Medical) Earnings per Share (Diluted) : $-0.32 (TTM As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Icecure Medical Earnings per Share (Diluted)?

Icecure Medical's Earnings per Share (Diluted) for the three months ended in Dec. 2023 was $-0.07. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.32.

Icecure Medical's EPS (Basic) for the three months ended in Dec. 2023 was $-0.07. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.32.

Icecure Medical's EPS without NRI for the three months ended in Dec. 2023 was $-0.07. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.32.

During the past 3 years, the average EPS without NRIGrowth Rate was -13.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was -5.00% per year. During the past 10 years, the average EPS without NRI Growth Rate was 23.70% per year.

During the past 11 years, Icecure Medical's highest 3-Year average EPS without NRI Growth Rate was 56.00% per year. The lowest was -13.30% per year. And the median was 19.50% per year.


Icecure Medical Earnings per Share (Diluted) Historical Data

The historical data trend for Icecure Medical's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Icecure Medical Earnings per Share (Diluted) Chart

Icecure Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Earnings per Share (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.35 -0.22 -0.35 -0.46 -0.32

Icecure Medical Quarterly Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.11 -0.08 -0.09 -0.09 -0.07

Competitive Comparison of Icecure Medical's Earnings per Share (Diluted)

For the Medical Devices subindustry, Icecure Medical's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Icecure Medical's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Icecure Medical's PE Ratio distribution charts can be found below:

* The bar in red indicates where Icecure Medical's PE Ratio falls into.



Icecure Medical Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Icecure Medical's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-14.652-0)/45.638
=-0.32

Icecure Medical's Earnings Per Share (Diluted) for the quarter that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (Q: Dec. 2023 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(-2.995-0)/45.673
=-0.07

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Icecure Medical  (NAS:ICCM) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Icecure Medical Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Icecure Medical's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Icecure Medical (Icecure Medical) Business Description

Traded in Other Exchanges
N/A
Address
7 Haeshel Street, Southern Industrial Park, PO Box 3163, Caesarea, ISR, 3079504
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

Icecure Medical (Icecure Medical) Headlines

From GuruFocus